Genotype-phenotype links in frontotemporal lobar degeneration

Nature Reviews. Neurology
Sara Van MosseveldeChristine Van Broeckhoven

Abstract

Frontotemporal lobar degeneration (FTLD) represents a group of neurodegenerative brain diseases with highly heterogeneous clinical, neuropathological and genetic characteristics. This high degree of heterogeneity results from the presence of several different underlying molecular disease processes; consequently, it is unlikely that all patients with FTLD will benefit from a single therapy. Therapeutic strategies for FTLD are currently being explored, and tools are urgently needed that enable the selection of patients who are the most likely to benefit from a particular therapy. Definition of the phenotypic characteristics in patients with different FTLD subtypes that share the same underlying disease processes would assist in the stratification of patients into homogeneous groups. The most common subtype of FTLD is characterized by TAR DNA-binding protein 43 (TDP43) pathology (FTLD-TDP). In this group, pathogenic mutations have been identified in four genes: C9orf72, GRN, TBK1 and VCP. Here, we provide a comprehensive overview of the phenotypic characteristics of patients with FTLD-TDP, highlighting shared features and differences among groups of patients who have a pathogenic mutation in one of these four genes.

References

Nov 11, 1988·Neuroscience Letters·P N LeighD M Power
Jun 18, 1998·Annals of Neurology·P PoorkajG D Schellenberg
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·M G SpillantiniB Ghetti
Aug 13, 2004·Neuropathology and Applied Neurobiology·K A JosephsT Revesz
Jul 26, 2005·Nature Genetics·Gaia SkibinskiJohn Collinge
Jun 20, 2006·Journal of Neuropathology and Experimental Neurology·Mark S FormanVirginia E Kimonis
Sep 5, 2006·Human Molecular Genetics·Jennifer GassRosa Rademakers
Oct 31, 2006·Brain : a Journal of Neurology·Ian R A MackenzieHoward H Feldman
Dec 13, 2006·Neurobiology of Aging·Luisa BenussiRoberta Ghidoni
Jan 11, 2007·Archives of Neurology·Marsel MesulamNeill R Graff-Radford
Jan 18, 2007·European Journal of Human Genetics : EJHG·Iraad F BronnerJohn C van Swieten
Feb 7, 2007·Journal of Neuropathology and Experimental Neurology·Keith A JosephsDennis W Dickson
Feb 7, 2007·Journal of Neuropathology and Experimental Neurology·Manuela NeumannMark S Forman
Mar 9, 2007·Human Mutation·Julie van der ZeeChristine Van Broeckhoven
Mar 21, 2007·Journal of Neurology, Neurosurgery, and Psychiatry·J C SchymickB J Traynor
Apr 17, 2007·Human Mutation·Isabelle Le BerUNKNOWN French Research Network on FTD/FTD-MND
Jun 27, 2007·The American Journal of Pathology·Nigel J CairnsIan R A Mackenzie
Oct 6, 2007·Journal of Neuropathology and Experimental Neurology·Salvatore SpinaBernardino Ghetti
Oct 10, 2007·Archives of Neurology·Nathalie BrouwersKristel Sleegers
Oct 24, 2007·Neurobiology of Aging·Brendan J KelleyRonald C Petersen
Oct 24, 2007·Biological Psychiatry·Adolfo López de MunainJosé Félix Martí Massó
Jan 11, 2008·Neurology·K SleegersC Van Broeckhoven
Feb 5, 2008·Brain : a Journal of Neurology·Isabelle Le BerUNKNOWN French research network on FTD/FTD-MND
Feb 9, 2008·American Journal of Medical Genetics. Part a·Virginia E KimonisGiles D J Watts
Aug 16, 2008·Neurology·H SeelaarJ C van Swieten
Nov 18, 2008·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Huei-Hsin ChiangCaroline Graff

❮ Previous
Next ❯

Citations

Jun 25, 2020·Translational Neurodegeneration·Julia RemnestålPeter Nilsson
Jul 28, 2018·Scientific Reports·Itaru YamamotoMasamitsu Yamaguchi
Apr 16, 2019·Frontiers in Neuroscience·Alberto BenussiBarbara Borroni
Jul 11, 2019·PloS One·Xiaolai ZhouFenghua Hu
Jan 31, 2020·Acta Neuropathologica Communications·Tatiana OrmeJose Bras
Apr 15, 2020·Annals of Neurology·Gabriella Le BlancUNKNOWN Genetic Frontotemporal Dementia Initiative (GENFI)
Sep 27, 2019·Acta Neuropathologica·Ito KawakamiMasato Hasegawa
Nov 7, 2019·Current Genetic Medicine Reports·Daniel W SirkisJennifer S Yokoyama
Mar 20, 2020·Proceedings of the National Academy of Sciences of the United States of America·Amantha Thathiah
Oct 6, 2020·Journal of Alzheimer's Disease : JAD·Cinzia CoppolaGiacomina Rossi
Apr 30, 2019·Frontiers in Neuroscience·Britt A Berning, Adam K Walker
Sep 19, 2020·Neurology·Beatrice CostaUNKNOWN International FTD-Genetics Consortium
Feb 5, 2021·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Yaling JiangLu Shen
Nov 19, 2020·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·E E Vasenina, O S Levin
Sep 26, 2020·Neurobiology of Aging·Irene RosasManuel Menéndez-González
Dec 22, 2019·Current Opinion in Neurobiology·Takashi Nonaka, Masato Hasegawa
May 19, 2020·Cortex; a Journal Devoted to the Study of the Nervous System and Behavior·Aino Yliranta, Mervi Jehkonen
Nov 7, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Eduardo de Pablo-FernándezThomas T Warner
May 23, 2020·Neurobiology of Disease·Rita GuerreiroJose Bras
Jun 25, 2021·Neurobiology of Aging·Sevilhan ArtanMurat Emre
Jun 22, 2021·Frontiers in Neurology·Sophia R L Vieira, Huw R Morris

❮ Previous
Next ❯

Methods Mentioned

BETA
nucleotide exchange

Related Concepts

Related Feeds

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.